Amylyx Pharmaceuticals Inc (AMLX)
2.03
+0.03
(+1.50%)
USD |
NASDAQ |
May 03, 16:00
2.035
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Cash from Operations (Quarterly): 13.55M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 13.55M |
| September 30, 2023 | -5.169M |
| June 30, 2023 | 8.609M |
| March 31, 2023 | -5.072M |
| December 31, 2022 | -49.70M |
| September 30, 2022 | -43.08M |
| Date | Value |
|---|---|
| June 30, 2022 | -46.46M |
| March 31, 2022 | -40.63M |
| December 31, 2021 | -28.24M |
| September 30, 2021 | -20.86M |
| June 30, 2021 | -13.05M |
| March 31, 2021 | -12.64M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-49.70M
Minimum
Dec 2022
13.55M
Maximum
Dec 2023
-20.23M
Average
-16.96M
Median
Cash from Operations (Quarterly) Benchmarks
| Cassava Sciences Inc | -22.32M |
| iRhythm Technologies Inc | -15.97M |
| Bristol-Myers Squibb Co | 2.834B |
| Moderna Inc | -989.00M |
| ACADIA Pharmaceuticals Inc | 85.39M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 20.92M |
| Cash from Financing (Quarterly) | 0.23M |
| Free Cash Flow | 10.68M |
| Free Cash Flow Per Share (Quarterly) | 0.1898 |
| Free Cash Flow to Equity (Quarterly) | 13.20M |
| Free Cash Flow to Firm (Quarterly) | 13.20M |
| Free Cash Flow Yield | 7.51% |